Status:
COMPLETED
Efficacy of a New Delivery System for Beta-hydroxy-beta-methylbutyrate
Lead Sponsor:
Metabolic Technologies Inc.
Collaborating Sponsors:
Iowa State University
Conditions:
Healthy
Eligibility:
All Genders
18-40 years
Phase:
PHASE1
Brief Summary
The proposed study will test efficacy of HMB in free acid gel to decrease muscle damage, diminish inflammatory response, and improve muscle strength recovery following an acute exercise stress. HMB in...
Eligibility Criteria
Inclusion
- Must live within 50 miles of Ames, Iowa
- Free of cardiac, liver, pulmonary, and kidney disease
- Free of chronic inflammatory disease including rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, and psoriasis
- Free diabetes mellitus
- Not classified as morbidly obese (BMI must be less than 40)
- Free of cardiac, liver, pulmonary, and kidney disease
- No other serious medical illness
- Normal menstrual cycle and not pregnant or lactating
- Able to consume supplements and perform required exercise testing
Exclusion
- Live more than 50 miles from Ames, Iowa
- Presence of cardiac, liver, pulmonary, and kidney disease
- Presence of chronic inflammatory disease including rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, and psoriasis
- Diabetes mellitus
- Classified as morbidly obese (BMI is greater than 40)
- No other serious medical illness
- Abnormal menstrual cycle, pregnant or lactating
- Not able to consume supplements and perform required exercise testing
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT01150526
Start Date
October 1 2010
End Date
July 1 2012
Last Update
July 18 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iowa State University
Ames, Iowa, United States, 50010